Hormonal strategy for the primary or secondary treatment of endometriosis

References

• Giudice LC. Clinical practice. Endometriosis. N. Engl. J. Med. 362(25), 2389–2398 (2010).
   PubMed Web of Science ®Google Scholar
• Viganò P, Somigliana E, Gentilini D, Benaglia L, Vercellini P. Back to the original question in endometriosis: implantation or metaplasia? J. Endometriosis 1, 1–8 (2009).
   Google Scholar
• Lafay Pillet MC, Schneider A, Borghese B et al. Deep infiltrating endometriosis is associated with markedly lower body mass index: a 476 case–control study. Hum. Reprod. 27(1), 265–272 (2012).
   PubMedGoogle Scholar
• Fauconnier A, Chapron C. Endometriosis and pelvic pain: epidemiological evidence of the relationship and implications. Hum. Reprod. Update 11(6), 595–606 (2005).
   PubMed Web of Science ®Google Scholar
• Vercellini P, Somigliana E, Viganò P, Abbiati A, Daguati R, Crosignani PG. Endometriosis: current and future medical therapies. Best Pract. Res. Clin. Obstet. Gynaecol. 22(2), 275–306 (2008).
   PubMed Web of Science ®Google Scholar
• Practice Commitee of the American Society for Reproductive Medicine. Treatment of pelvic pain associated with endometriosis. Fertil. Steril. 3, 260–269 (2008).
   Google Scholar
• Millar RP, Pawson AJ, Morgan K, Rissman EF, Lu ZL. Diversity of actions of GnRHs mediated by ligand-induced selective signaling. Front. Neuroendocrinol. 29(1), 17–35 (2008).
   PubMed Web of Science ®Google Scholar
• Guillemin R. Hypothalamic hormones a.k.a. hypothalamic releasing factors. J. Endocrinol. 184(1), 11–28 (2005).
   PubMed Web of Science ®Google Scholar
• Prentice A, Deary AJ, Goldbeck-Wood S, Farquhar C, Smith SK. WITHDRAWN: Gonadotrophin-releasing hormone analogues for pain associated with endometriosis. Cochrane Database Syst. Rev. (2), CD000346 (1999).
   Google Scholar
• Batzer FR. GnRH analogs: options for endometriosis-associated pain treatment. J. Minim. Invasive Gynecol. 13(6), 539–545 (2006).
   PubMed Web of Science ®Google Scholar
• Brown J, Pan A, Hart RJ. Gonadotrophin-releasing hormone analogues for pain associated with endometriosis. Cochrane Database Syst. Rev. (12), CD008475 (2010).
   Google Scholar
• Pickersgill A. GnRH agonists and add-back therapy: is there a perfect combination? Br. J. Obstet. Gynaecol. 105(5), 475–485 (1998).
   PubMedGoogle Scholar
• Bedaiwy MA, Casper RF. Treatment with leuprolide acetate and hormonal add-back for up to 10 years in stage IV endometriosis patients with chronic pelvic pain. Fertil. Steril. 86(1), 220–222 (2006).
   PubMed Web of Science ®Google Scholar
• Surrey ES, Hornstein MD. Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up. Obstet. Gynecol. 99(5 Pt 1), 709–719 (2002).
   PubMed Web of Science ®Google Scholar
• Kim NY, Ryoo U, Lee DY, Kim MJ, Yoon BK, Choi D. The efficacy and tolerability of short-term low-dose estrogen-only add-back therapy during post-operative GnRH agonist treatment for endometriosis. Eur. J. Obstet. Gynecol. Reprod. Biol. 154(1), 85–89 (2011).
   PubMed Web of Science ®Google Scholar
• Park HJ, Koo YA, Yoon BK, Choi D. Postoperative long-term maintenance therapy with oral contraceptives after gonadotropin-releasing hormone analog treatment in women with ovarian endometrioma. J. Minim. Invasive Gynecol. 16(1), 34–39 (2009).
   PubMed Web of Science ®Google Scholar
• Pettersson G, Andersen AN, Broberg P, Arce JC. Pre-stimulation parameters predicting live birth after IVFin the long GnRH agonist protocol. Reprod. Biomed. Online 20(5), 572–581 (2010).
   PubMedGoogle Scholar
• Tavmergen E, Ulukus M, Goker EN. Long-term use of gonadotropin-releasing hormone analogues before IVF in women with endometriosis. Curr. Opin. Obstet. Gynecol. 19(3), 284–288 (2007).
   PubMed Web of Science ®Google Scholar
• Waller KG, Shaw RW. Gonadotropin-releasing hormone analogues for the treatment of endometriosis: long-term follow-up. Fertil. Steril. 59(3), 511–515 (1993).
   PubMed Web of Science ®Google Scholar
• Kang JL, Wang XX, Nie ML, Huang XH. Efficacy of gonadotropin-releasing hormone agonist and an extended-interval dosing regimen in the treatment of patients with adenomyosis and endometriosis. Gynecol. Obstet. Invest. 69(2), 73–77 (2010).
   PubMed Web of Science ®Google Scholar
• Falcone T, Lebovic DI. Clinical management of endometriosis. Obstet. Gynecol. 118(3), 691–705 (2011).
   PubMed Web of Science ®Google Scholar
• Engel JB, Schally AV. Drug insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone. Nat. Clin. Pract. Endocrinol. Metab. 3(2), 157–167 (2007).
   PubMedGoogle Scholar
• Tahara M, Matsuoka T, Yokoi T, Tasaka K, Kurachi H, Murata Y. Treatment of endometriosis with adecreasing dosage of a gonadotropin-releasing hormone agonist (nafarelin): a pilot study with low-dose agonist therapy (‘draw-back’ therapy). Fertil. Steril. 73(4), 799–804 (2000).
   PubMed Web of Science ®Google Scholar
• Struthers RS, Nicholls AJ, Grundy J et al. Suppression of gonadotropins and estradiol in premenopausal women by oral administration of the nonpeptide gonadotropin-releasing hormone antagonist elagolix. J. Clin. Endocrinol. Metab. 94(2), 545–551 (2009).
   PubMed Web of Science ®Google Scholar
• Cetel NS, Rivier J, Vale W, Yen SS. The dynamics of gonadotropin inhibition in women induced by an antagonistic analog of gonadotropin-releasing hormone. J. Clin. Endocrinol. Metab. 57(1), 62–65 (1983).
   PubMed Web of Science ®Google Scholar
• McLeod D, Zinner N, Tomera K et al.; Abarelix Study Group. A Phase 3, multicenter, open-label, randomized study of abarelix versus leuprolide acetate in men with prostate cancer. Urology 58(5), 756–761 (2001).
   PubMed Web of Science ®Google Scholar
• Trachtenberg J, Gittleman M, Steidle C et al.; Abarelix Study Group. A Phase 3, multicenter, open label, randomized study of abarelix versus leuprolide plus daily antiandrogen in men with prostate cancer. J. Urol. 167(4), 1670–1674 (2002).
   PubMed Web of Science ®Google Scholar
• Struthers RS, Xie Q, Sullivan SK et al. Pharmacological characterization of a novel nonpeptide antagonist of the human gonadotropin-releasing hormone receptor, NBI-42902. Endocrinology 148(2), 857–867 (2007).
   PubMed Web of Science ®Google Scholar
• Küpker W, Felberbaum RE, Krapp M, Schill T, Malik E, Diedrich K. Use of GnRH antagonists in the treatment of endometriosis. Reprod. Biomed. Online 5(1), 12–16 (2002).
   PubMedGoogle Scholar
• Meresman GF, Bilotas M, Abello V, Buquet R, Tesone M, Sueldo C. Effects of aromatase inhibitors on proliferation and apoptosis in eutopic endometrial cell cultures from patients with endometriosis. Fertil. Steril. 84(2), 459–463 (2005).
   PubMed Web of Science ®Google Scholar
• Zeitoun KM, Bulun SE. Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target. Fertil. Steril. 72(6), 961–969 (1999).
   PubMed Web of Science ®Google Scholar
• Bulun SE, Fang Z, Imir G et al. Aromatase and endometriosis. Semin. Reprod. Med. 22(1), 45–50 (2004).
   PubMed Web of Science ®Google Scholar
• Bulun S. Aromatase p-450 messenger RNA expression in eutopic endometrium is not a specific marker for pelvic endometriosis: molecular basis and clinical relevance. Fertil. Steril. 78, 825–829 (2002).
   PubMedGoogle Scholar
• Colette S, Lousse JC, Defrère S et al. Absence of aromatase protein and mRNA expression in endometriosis. Hum. Reprod. 24(9), 2133–2141 (2009).
   PubMed Web of Science ®Google Scholar
• Patwardhan S, Nawathe A, Yates D, Harrison GR, Khan KS. Systematic review of the effects of aromatase inhibitors on pain associated with endometriosis. BJOG 115, 818–822 (2008).
   PubMed Web of Science ®Google Scholar
• Miller WR, Anderson TJ, Dixon JM. Anti-tumor effects of letrozole. Cancer Invest. 20(Suppl. 2), 15–21 (2002).
   PubMed Web of Science ®Google Scholar
• Hefler LA, Grimm C, van Trotsenburg M, Nagele F. Role of the vaginally administered aromatase inhibitor anastrozole in women with rectovaginal endometriosis: a pilot study. Fertil. Steril. 84(4), 1033–1036 (2005).
   PubMed Web of Science ®Google Scholar
• Verma A, Konje JC. Successful treatment of refractory endometriosis-related chronic pelvic pain with aromatase inhibitors in premenopausal patients. Eur. J. Obstet. Gynecol. Reprod. Biol. 143(2), 112–115 (2009).
   PubMed Web of Science ®Google Scholar
• Razzi S, Fava A, Sartini A, De Simone S, Cobellis L, Petraglia F. Treatment of severe recurrent endometriosis with an aromatase inhibitor in a young ovariectomised woman. BJOG 111(2), 182–184 (2004).
   PubMed Web of Science ®Google Scholar
• Ailawadi RK, Jobanputra S, Kataria M, Gurates B, Bulun SE. Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study. Fertil. Steril. 81(2), 290–296 (2004).
   PubMed Web of Science ®Google Scholar
• Amsterdam LL, Gentry W, Jobanputra S, Wolf M, Rubin SD, Bulun SE. Anastrazole and oral contraceptives: a novel treatment for endometriosis. Fertil. Steril. 84(2), 300–304 (2005).
   PubMed Web of Science ®Google Scholar
• Soysal S, Soysal ME, Ozer S, Gul N, Gezgin T. The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial. Hum. Reprod. 19(1), 160–167 (2004).
   PubMed Web of Science ®Google Scholar
• Ferrero S, Camerini G, Seracchioli R, Ragni N, Venturini PL, Remorgida V. Letrozole combined with norethisterone acetate compared with norethisterone acetate alone in the treatment of pain symptoms caused by endometriosis. Hum. Reprod. 24(12), 3033–3041 (2009).
   PubMed Web of Science ®Google Scholar
• Ferrero S, Gillott DJ, Venturini PL, Remorgida V. Use of aromatase inhibitors to treat endometriosis-related pain symptoms: a systematic review. Reprod. Biol. Endocrinol. 9, 89 (2011).
   PubMed Web of Science ®Google Scholar
• Lossl K, Loft A, Freiesleben NL et al. Combined down-regulation by aromatase inhibitor and GnRH-agonist in IVF patients with endometriomas – a pilot study. Eur. J. Obstet. Gynecol. Reprod. Biol. 144(1), 48–53 (2009).
   PubMed Web of Science ®Google Scholar
• Healey S, Tan SL, Tulandi T, Biljan MM. Effects of letrozole on superovulation with gonadotropins in women undergoing intrauterine insemination. Fertil. Steril. 80(6), 1325–1329 (2003).
   PubMed Web of Science ®Google Scholar
• Vercellini P, Fedele L, Pietropaolo G, Frontino G, Somigliana E, Crosignani PG. Progestogens for endometriosis: forward to the past. Hum. Reprod. Update 9(4), 387–396 (2003).
   PubMed Web of Science ®Google Scholar
• Vercellini P, Somigliana E, Viganò P et al. Endometriosis: current and future medical therapies. Best Pract. Res. Clin. Obstet. Gynaecol. 22, 275–306 (2008).
   PubMed Web of Science ®Google Scholar
• Surrey ES. The role of progestins in treating the pain of endometriosis. J. Minim. Invasive Gynecol. 13(6), 528–534 (2006).
   PubMed Web of Science ®Google Scholar
• Bergqvist A, Theorell T. Changes in quality of life after hormonal treatment of endometriosis. Acta Obstet. Gynecol. Scand. 80(7), 628–637 (2001).
   PubMed Web of Science ®Google Scholar
• Razzi S, Luisi S, Ferretti C et al. Use of a progestogen only preparation containing desogestrel in the treatment of recurrent pelvic pain after conservative surgery for endometriosis. Eur. J. Obstet. Gynecol. Reprod. Biol. 135(2), 188–190 (2007).
   PubMed Web of Science ®Google Scholar
• Sasagawa S, Shimizu Y, Kami H et al. Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile. Steroids 73(2), 222–231 (2008).
   PubMed Web of Science ®Google Scholar
• Strowitzki T, Faustmann T, Gerlinger C, Seitz C. Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study. Eur. J. Obstet. Gynecol. Reprod. Biol. 151(2), 193–198 (2010).
   PubMed Web of Science ®Google Scholar
• Harada T, Momoeda M, Taketani Y et al. Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis – a randomized, double-blind, multicenter, controlled trial. Fertil. Steril. 91(3), 675–681 (2009).
   PubMed Web of Science ®Google Scholar
• Strowitzki T, Marr J, Gerlinger C, Faustmann T, Seitz C. Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial. Hum. Reprod. 25(3), 633–641 (2010).
   PubMed Web of Science ®Google Scholar
• Petraglia F, Hornung D, Seitz C et al. Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment. Arch. Gynecol. Obstet. 285, 167–173 (2011).
   PubMedGoogle Scholar
• Takamura M, Koga K, Osuga Y et al. Post-operative oral contraceptive use reduces the risk of ovarian endometrioma recurrence after laparoscopic excision. Hum. Reprod. 24(12), 3042–3048 (2009).
   PubMed Web of Science ®Google Scholar
• Bahamondes L, Petta CA, Fernandes A, Monteiro I. Use of the levonorgestrel-releasing intrauterine system in women with endometriosis, chronic pelvic pain and dysmenorrhea. Contraception 75(Suppl. 6), S134–S139 (2007).
   PubMed Web of Science ®Google Scholar
• Lockhat FB, Emembolu JO, Konje JC. The evaluation of the effectiveness of an intrauterine-administered progestogen (levonorgestrel) in the symptomatic treatment of endometriosis and in the staging of the disease. Hum. Reprod. 19(1), 179–184 (2004).
   PubMed Web of Science ®Google Scholar
• Lockhat FB, Emembolu JO, Konje JC. The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3 year follow-up. Hum. Reprod. 20(3), 789–793 (2005).
   PubMed Web of Science ®Google Scholar
• Petta CA, Ferriani RA, Abrao MS et al. Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis. Hum. Reprod. 20(7), 1993–1998 (2005).
   PubMed Web of Science ®Google Scholar
• Vercellini P, Aimi G, Panazza S, De Giorgi O, Pesole A, Crosignani PG. A levonorgestrel-releasing intrauterine system for the treatment of dysmenorrhea associated with endometriosis: a pilot study. Fertil. Steril. 72(3), 505–508 (1999).
   PubMed Web of Science ®Google Scholar
• Fedele L, Bianchi S, Zanconato G, Portuese A, Raffaelli R. Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis. Fertil. Steril. 75(3), 485–488 (2001).
   PubMed Web of Science ®Google Scholar
• Crosignani P, Olive D, Bergqvist A, Luciano A. Advances in the management of endometriosis: an update for clinicians. Hum. Reprod. Update 12(2), 179–189 (2006).
   PubMed Web of Science ®Google Scholar
• Selak V, Farquhar C, Prentice A, Singla A. Danazol for pelvic pain associated with endometriosis. Cochrane Database Syst. Rev. (4), CD000068 (2007).
   Google Scholar
• Razzi S, Luisi S, Calonaci F, Altomare A, Bocchi C, Petraglia F. Efficacy of vaginal danazol treatment in women with recurrent deeply infiltrating endometriosis. Fertil. Steril. 88(4), 789–794 (2007).
   PubMed Web of Science ®Google Scholar
• Igarashi M, Iizuka M, Abe Y, Ibuki Y. Novel vaginal danazol ring therapy for pelvic endometriosis, in particular deeply infiltrating endometriosis. Hum. Reprod. 13(7), 1952–1956 (1998).
   PubMed Web of Science ®Google Scholar
• Janicki TI, Dmowski WP. Intravaginal danazol significantly reduces chronic pelvic pain in women with endometriosis. Obstet. Gynecol. Suppl. 11(2), 266 (2004) (Abstract).
   Google Scholar
• Cobellis L, Razzi S, Fava A, Severi FM, Igarashi M, Petraglia F. A danazol-loaded intrauterine device decreases dysmenorrhea, pelvic pain, and dyspareunia associated with endometriosis. Fertil. Steril. 82(1), 239–240 (2004).
   PubMed Web of Science ®Google Scholar
• Practice Committee of the American Society for Reproductive Medicine. Treatment of pelvic pain associated with endometriosis. Fertil. Steril. 865, 18–27 (2006).
   Google Scholar
• Vercellini P, Cortesi I, Crosignani PG. Progestins for symptomatic endometriosis: a critical analysis of the evidence. Fertil. Steril. 68(3), 393–401 (1997).
   PubMed Web of Science ®Google Scholar
• Vercellini P, Eskenazi B, Consonni D et al. Oral contraceptives and endometriosis: dangerous liason or protective measure? A systematic review. Hum. Reprod. Update 17(2), 159–170 (2010).
   PubMedGoogle Scholar
• Hirota Y, Osuga Y, Koga K et al. Possible implication of midkine in the development of endometriosis. Hum. Reprod. 20(4), 1084–1089 (2005).
   PubMedGoogle Scholar
• Kennedy S, Bergqvist A, Chapron C et al.; Special Interest Group for Endometriosis and Endometrium Guideline Development. ESHRE guideline for the diagnosis and treatment of endometriosis Hum. Reprod. 20(10) 2698–2704 (2005).
   PubMed Web of Science ®Google Scholar
• Somigliana E, Vercellini P, Vigano P, Abbiati A, Benaglia L, Fedele L. Endometriosis and estroprogestins: the chicken or the egg causality dilemma. Fertil. Steril. 95(1), 431–433 (2011).
   PubMedGoogle Scholar
• Chapron C, Souza C, Borghese B et al. Oral contraceptives and endometriosis: the past use of oral contraceptives for treating severe primary dysmenorrhea is associated with endometriosis, especially deep infiltrating endometriosis. Hum. Reprod. 26(8), 2028–2035 (2011).
   PubMed Web of Science ®Google Scholar
• Seracchioli R, Mabrouk M, Manuzzi L et al. Post-operative use of oral contraceptive pills for prevention of anatomical relapse or symptom-recurrence after conservative surgery for endometriosis. Hum. Reprod. 24(11), 2729–2735 (2009).
   PubMed Web of Science ®Google Scholar
• Takamura M, Koga K, Osuga Y et al. Post-operative oral contraceptive use reduces the risk of ovarian endometrioma recurrence after laparoscopic excision. Hum. Reprod. 24, 3042–3048 (2009).
   PubMed Web of Science ®Google Scholar
• Vercellini P, Frontino G, De Giorgi O, Pietropaolo G, Pasin R, Crosignani PG. Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen. Fertil. Steril. 80(3), 560–563 (2003).
   PubMed Web of Science ®Google Scholar